IL10 and hepatocellular carcinoma: There was a significant association between the IL-10 (-1082 A/G) and hepatocellular carcinoma in protection using the dominant model (OR: 0.62, 95% CI: 0.45–0.86, I2 = 33.1%, fixed effect model) and allelic model (G vs. A) (OR: 0.79, 95% CI: 0.64–0.99, I2 = 0.0%, fixed effect model) with the non-Asian population.